{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:46Z","timestamp":1747180846973,"version":"3.40.5"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>OBJECTIVES:<\/jats:title>\n            <jats:p>Cardiogenic shock (CS) is associated with high mortality. Patients treated for CS mostly require heparin therapy, which may be associated with complications such as heparin-induced thrombocytopenia (HIT). HIT represents a serious condition associated with platelet decline and increased hypercoagulability and remains a poorly researched field in intensive care medicine. Primary purpose of this study was to: 1) determine HIT prevalence in CS, 2) assess the performance of common diagnostic tests for the workup of HIT, and 3) compare outcomes in CS patients with excluded and confirmed HIT.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DESIGN:<\/jats:title>\n            <jats:p>Retrospective dual-center study including adult patients 18 years old or older with diagnosed CS and suspected HIT from January 2010 to November 2022.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>SETTING:<\/jats:title>\n            <jats:p>Cardiac ICU at the Ludwig-Maximilians University hospital in Munich and the university hospital of Bonn.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>PATIENTS AND INTERVENTIONS:<\/jats:title>\n            <jats:p>In this retrospective analysis, adult patients with diagnosed CS and suspected HIT were included. Differences in baseline characteristics, mortality, neurologic and safety outcomes between patients with excluded and confirmed HIT were evaluated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MEASUREMENTS AND MAIN RESULTS:<\/jats:title>\n            <jats:p>In cases of suspected HIT, positive screening antibodies were detected in 159 of 2808 patients (5.7%). HIT was confirmed via positive functional assay in 57 of 2808 patients, corresponding to a prevalence rate of 2.0%. The positive predictive value for anti-platelet factor 4\/heparin screening antibodies was 35.8%. Total in-hospital mortality (58.8% vs. 57.9%; <jats:italic toggle=\"yes\">p<\/jats:italic> &gt; 0.999), 1-month mortality (47.1% vs. 43.9%; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.781), and 12-month mortality (58.8% vs. 59.6%; <jats:italic toggle=\"yes\">p<\/jats:italic> &gt; 0.999) were similar between patients with excluded and confirmed HIT, respectively. Furthermore, no significant difference in neurologic outcome among survivors was found between groups (Cerebral Performance Category [CPC] score 1: 8.8% vs. 8.8%; <jats:italic toggle=\"yes\">p<\/jats:italic> &gt; 0.999 and CPC 2: 7.8% vs. 12.3%; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.485).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>HIT was a rare complication in CS patients treated with unfractionated heparin and was not associated with increased mortality. Also, HIT confirmation was not associated with worse neurologic outcome in survivors. Future studies should aim at developing more precise, standardized, and cost-effective strategies to diagnose HIT and prevent complications.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cce.0000000000001117","type":"journal-article","created":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T20:59:39Z","timestamp":1721768379000},"page":"e1117","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Heparin-Induced Thrombocytopenia in Patients Suffering Cardiogenic Shock"],"prefix":"10.1097","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3214-5672","authenticated-orcid":false,"given":"Enzo","family":"L\u00fcsebrink","sequence":"first","affiliation":[{"name":"Medizinische Klinik und Poliklinik I, Klinikum der Universit\u00e4t M\u00fcnchen, Munich, Germany."},{"name":"DZHK (German Center for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo","family":"Lanz","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik I, Klinikum der Universit\u00e4t M\u00fcnchen, Munich, Germany."},{"name":"DZHK (German Center for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonhard","family":"Binzenh\u00f6fer","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik I, Klinikum der Universit\u00e4t M\u00fcnchen, Munich, Germany."},{"name":"DZHK (German Center for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Hoffmann","sequence":"additional","affiliation":[{"name":"Institute for Medical Information Processing, Biometry, and Epidemiology, Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen, Munich, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"H\u00f6pler","sequence":"additional","affiliation":[{"name":"Institute for Medical Information Processing, Biometry, and Epidemiology, Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen, Munich, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Kraft","sequence":"additional","affiliation":[{"name":"Institute for Medical Information Processing, Biometry, and Epidemiology, Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen, Munich, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nils","family":"Gade","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik I, Klinikum der Universit\u00e4t M\u00fcnchen, Munich, Germany."},{"name":"DZHK (German Center for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas","family":"Gmeiner","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik I, Klinikum der Universit\u00e4t M\u00fcnchen, Munich, Germany."},{"name":"DZHK (German Center for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Roden","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik I, Klinikum der Universit\u00e4t M\u00fcnchen, Munich, Germany."},{"name":"DZHK (German Center for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inas","family":"Saleh","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik I, Klinikum der Universit\u00e4t M\u00fcnchen, Munich, Germany."},{"name":"DZHK (German Center for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Hagl","sequence":"additional","affiliation":[{"name":"DZHK (German Center for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany."},{"name":"Herzchirurgische Klinik und Poliklinik, Klinikum der Universit\u00e4t M\u00fcnchen, Munich, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"Nickenig","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik II, Universit\u00e4tsklinikum Bonn, Bonn, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steffen","family":"Massberg","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik I, Klinikum der Universit\u00e4t M\u00fcnchen, Munich, Germany."},{"name":"DZHK (German Center for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Zimmer","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik II, Universit\u00e4tsklinikum Bonn, Bonn, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ra\u00fal Nicol\u00e1s","family":"Jamin","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik II, Universit\u00e4tsklinikum Bonn, Bonn, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clemens","family":"Scherer","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik I, Klinikum der Universit\u00e4t M\u00fcnchen, Munich, Germany."},{"name":"DZHK (German Center for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,7,22]]},"reference":[{"key":"R1-20240806","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1161\/CIRCULATIONAHA.123.064527","article-title":"Standardized definitions for cardiogenic shock research and mechanical circulatory support devices: Scientific expert panel from the shock academic research consortium (SHARC).","volume":"148","author":"Waksman","year":"2023","journal-title":"Circulation"},{"key":"R2-20240806","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/ccd.28329","article-title":"SCAI clinical expert consensus statement on the classification of cardiogenic shock: This document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019.","volume":"94","author":"Baran","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"R3-20240806","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJM199908263410901","article-title":"Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock.","volume":"341","author":"Hochman","year":"1999","journal-title":"N Engl J Med"},{"key":"R4-20240806","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1208410","article-title":"Intraaortic balloon support for myocardial infarction with cardiogenic shock.","volume":"367","author":"Thiele","year":"2012","journal-title":"N Engl J Med"},{"key":"R5-20240806","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJMoa2307227","article-title":"Extracorporeal life support in infarct-related cardiogenic shock.","volume":"389","author":"Thiele","year":"2023","journal-title":"N Engl J Med"},{"key":"R6-20240806","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1007\/s00134-020-06031-4","article-title":"Platelets and extra-corporeal membrane oxygenation in adult patients: A systematic review and meta-analysis.","volume":"46","author":"Jiritano","year":"2020","journal-title":"Intensive Care Med"},{"key":"R7-20240806","doi-asserted-by":"crossref","first-page":"e01","DOI":"10.15420\/cfr.2019.02","article-title":"Temporary mechanical circulatory support in acute heart failure.","volume":"6","author":"Jiritano","year":"2020","journal-title":"Card Fail Rev"},{"key":"R8-20240806","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1182\/asheducation-2017.1.660","article-title":"Assessing thrombocytopenia in the intensive care unit: The past, present, and future.","volume":"2017","author":"Zarychanski","year":"2017","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"R9-20240806","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMcp1411910","article-title":"CLINICAL PRACTICE. Heparin-induced thrombocytopenia.","volume":"373","author":"Greinacher","year":"2015","journal-title":"N Engl J Med"},{"key":"R10-20240806","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.thromres.2020.01.026","article-title":"Heparin-induced thrombocytopenia: Diagnostic challenges in intensive care patients especially with extracorporeal circulation.","volume":"188","author":"Althaus","year":"2020","journal-title":"Thromb Res"},{"key":"R11-20240806","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1007\/s00134-018-5346-y","article-title":"Prevalence and outcome of heparin-induced thrombocytopenia diagnosed under veno-arterial extracorporeal membrane oxygenation: A retrospective nationwide study.","volume":"44","author":"Kimmoun","year":"2018","journal-title":"Intensive Care Med"},{"key":"R12-20240806","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3390\/jcm12010362","article-title":"Heparin-induced thrombocytopenia in patients undergoing venoarterial extracorporeal membrane oxygenation.","volume":"12","author":"L\u00fcsebrink","year":"2023","journal-title":"J Clin Med"},{"key":"R13-20240806","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/j.jacc.2016.02.073","article-title":"Heparin-induced thrombocytopenia: A comprehensive clinical review.","volume":"67","author":"Salter","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R14-20240806","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1538-7836.2006.01787.x","article-title":"Evaluation of pretest clinical score (4 T\u2019s) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings.","volume":"4","author":"Lo","year":"2006","journal-title":"J Thromb Haemost"},{"key":"R15-20240806","doi-asserted-by":"crossref","first-page":"470.e7","DOI":"10.1016\/j.jcrc.2014.02.004","article-title":"Heparin-induced thrombocytopenia in the critically ill: Interpreting the 4Ts test in a randomized trial.","volume":"29","author":"Crowther","year":"2014","journal-title":"J Crit Care"},{"key":"R16-20240806","first-page":"429","article-title":"Evaluation of heparin-induced thrombocytopenia (HIT) laboratory testing and the 4Ts scoring system in the intensive care unit.","volume":"43","author":"Pierce","year":"2013","journal-title":"Ann Clin Lab Sci"},{"key":"R17-20240806","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jcrc.2013.12.010","article-title":"Assessment of a modified 4T scoring system for heparin-induced thrombocytopenia in critically ill patients.","volume":"29","author":"Fiorenza","year":"2014","journal-title":"J Crit Care"},{"key":"R18-20240806","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/01.CCM.0000259538.02375.A5","article-title":"Heparin-induced thrombocytopenia in intensive care patients.","volume":"35","author":"Selleng","year":"2007","journal-title":"Crit Care Med"},{"key":"R19-20240806","doi-asserted-by":"crossref","first-page":"e1031","DOI":"10.1097\/CCM.0000000000001869","article-title":"Platelet count trends and prevalence of heparin-induced thrombocytopenia in a cohort of extracorporeal membrane oxygenator patients.","volume":"44","author":"Sokolovic","year":"2016","journal-title":"Crit Care Med"},{"key":"R20-20240806","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s11239-021-02546-9","article-title":"Heparin-induced thrombocytopenia in extra-corporeal membrane oxygenation: Epidemiology, outcomes, and diagnostic challenges.","volume":"53","author":"Zaaqoq","year":"2022","journal-title":"J Thromb Thrombolysis"},{"key":"R21-20240806","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1161\/CIRCULATIONAHA.118.036691","article-title":"Venoarterial extracorporeal membrane oxygenation for cardiopulmonary support.","volume":"138","author":"Becher","year":"2018","journal-title":"Circulation"},{"key":"R22-20240806","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1055\/s-0037-1606179","article-title":"Bleeding and thrombotic complications in the use of extracorporeal membrane oxygenation.","volume":"44","author":"Thomas","year":"2018","journal-title":"Semin Thromb Hemost"},{"key":"R23-20240806","doi-asserted-by":"crossref","first-page":"e0183193","DOI":"10.1371\/journal.pone.0183193","article-title":"Acquired von Willebrand syndrome in cardiogenic shock patients on mechanical circulatory microaxial pump support.","volume":"12","author":"Flierl","year":"2017","journal-title":"PLoS One"},{"key":"R24-20240806","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1378\/chest.10-2243","article-title":"The frequency and clinical significance of thrombocytopenia complicating critical illness: A systematic review.","volume":"139","author":"Hui","year":"2011","journal-title":"Chest"},{"key":"R25-20240806","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1182\/bloodadvances.2018024489","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: Heparin-induced thrombocytopenia.","volume":"2","author":"Cuker","year":"2018","journal-title":"Blood Adv"},{"key":"R26-20240806","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1055\/s-0039-1688827","article-title":"Frequency and clinical impact of platelet factor 4-specific antibodies in patients undergoing extracorporeal membrane oxygenation.","volume":"119","author":"Vayne","year":"2019","journal-title":"Thromb Haemost"},{"key":"R27-20240806","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1177\/0267659119881266","article-title":"Predictive value of scoring tools in determining heparin-induced thrombocytopenia in patients on extracorporeal membrane oxygenation.","volume":"35","author":"Sullivan","year":"2020","journal-title":"Perfusion"},{"key":"R28-20240806","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1161\/01.CIR.103.14.1838","article-title":"Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia.","volume":"103","author":"Lewis","year":"2001","journal-title":"Circulation"},{"key":"R29-20240806","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1001\/archinte.163.15.1849","article-title":"Argatroban anticoagulation in patients with heparin-induced thrombocytopenia.","volume":"163","author":"Lewis","year":"2003","journal-title":"Arch Intern Med"},{"key":"R30-20240806","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1177\/03913988221106225","article-title":"Evaluation of anticoagulation with bivalirudin for heparin-induced thrombocytopenia during extracorporeal membrane oxygenation.","volume":"45","author":"Hanna","year":"2022","journal-title":"Int J Artif Organs"},{"key":"R31-20240806","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1160\/TH07-04-0252","article-title":"Fondaparinux for the treatment of patients with acute heparin-induced thrombocytopenia.","volume":"99","author":"Lobo","year":"2008","journal-title":"Thromb Haemost"},{"key":"R32-20240806","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/jth.14383","article-title":"An international external quality assessment for laboratory diagnosis of heparin-induced thrombocytopenia.","volume":"17","author":"Eekels","year":"2019","journal-title":"J Thromb Haemost"},{"key":"R33-20240806","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11239-014-1105-2","article-title":"Prevalence and clinical implications of anti-PF4\/heparin antibodies in intensive care patients: A prospective observational study.","volume":"39","author":"Selleng","year":"2015","journal-title":"J Thromb Thrombolysis"},{"key":"R34-20240806","doi-asserted-by":"crossref","first-page":"e507","DOI":"10.1055\/a-1653-5065","article-title":"Heparin-induced thrombocytopenia diagnosis: A retrospective study comparing heparin-induced platelet activation test to (14) C-serotonin release assay.","volume":"5","author":"Gonthier","year":"2021","journal-title":"TH Open"}],"container-title":["Critical Care Explorations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000001117","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T22:05:06Z","timestamp":1722981906000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000001117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":34,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/cce.0000000000001117","relation":{},"ISSN":["2639-8028"],"issn-type":[{"type":"electronic","value":"2639-8028"}],"subject":[],"published":{"date-parts":[[2024,7]]}}}